Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Equity Ratio (2016 - 2025)

Ptc Therapeutics has reported Equity Ratio over the past 14 years, most recently at 0.07 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.07 for Q4 2025, up 89.0% from a year ago — trailing twelve months through Dec 2025 was 0.07 (up 89.0% YoY), and the annual figure for FY2025 was 0.07, up 89.0%.
  • Equity Ratio for Q4 2025 was 0.07 at Ptc Therapeutics, down from 0.06 in the prior quarter.
  • Over the last five years, Equity Ratio for PTCT hit a ceiling of 0.14 in Q1 2021 and a floor of 0.64 in Q4 2024.
  • Median Equity Ratio over the past 5 years was 0.12 (2022), compared with a mean of 0.22.
  • Biggest five-year swings in Equity Ratio: plummeted 27526.0% in 2022 and later soared 89.71% in 2025.
  • Ptc Therapeutics' Equity Ratio stood at 0.0 in 2021, then plummeted by 27526.0% to 0.2 in 2022, then crashed by 112.19% to 0.43 in 2023, then plummeted by 49.15% to 0.64 in 2024, then surged by 89.0% to 0.07 in 2025.
  • The last three reported values for Equity Ratio were 0.07 (Q4 2025), 0.06 (Q3 2025), and 0.08 (Q2 2025) per Business Quant data.